Skip to content

Panchakarma therapy along with herbal medication used in treatment of Psoriasis

A Comparative Clinical Study Of Vamana & Virechana Karma and Followed By Aragwadha Patra Lepa With Shamana Yoga Lelitaka (GANDHAKA) in the Management of Kitibha Kushtha W.S.R. TO PSORIASIS ?

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012468
Enrollment
30
Registered
2018-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed Patients of Psoriasis as per classical sign and symptomes

Interventions

Intervention1: Group A Vamana Karma: Deepana Pachana with Panchkol Churna 3 gm BD for 3 days,Snehpana will be done with Tiktashatpala Ghritam till samyak sneha lakshana will be observed. Sarvanga

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1Patients who are willing for trial. 2Patients in the age group of 16– 60 years. 3Patient who are fit for Vamana and Virechana karma

Exclusion criteria

Exclusion criteria: 1Patients with age below 16 & above 60 yrs. 2Pregnant women’s & lactating mothers. 3Patients suffering from serious systemic disorders like Diabetes Mellitus, Cardiac & Renal Disorders, Malignant disease, Major liver disorders, immuno-compromised host, etc. 4Patients having complication of Psoriasis like Psoriatic Arthopathy, etc. 5Patients Contra indicated for Vamana Karma and Virechana karma as per classical Ayurvedic texts.

Design outcomes

Primary

MeasureTime frame
Improvement in Subjective and objective parametersTimepoint: 2 month

Secondary

MeasureTime frame
To find the comparative efficacy of treatment in different groupsTimepoint: 1 month

Countries

India

Contacts

Public ContactDr Govind Narayan

National Institute of Ayurveda

gmangal108@gmail.com8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026